Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The lab of one University of Illinois researcher is receiving a hefty grant, which will be used towards cancer research. On ...

Anchor] In the future, it is expected that it will be possible to develop an mRNA vaccine that is sucked into the respiratory ...

RNA vaccines were a groundbreaking development in the medicine community, and was known to have side effects like headaches, ...

Australian researchers have discovered why mRNA vaccines can cause side effects such as headaches and fevers in a breakthrough that they said could help improve the efficacy of vaccines, reported ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new ...

The case of avian influenza A (H5) confirmed by the Centers for Disease Control and Prevention in Missouri, USA, on Sept 6, 2024,1 has reignited concerns about the risk of human contagion and the need ...

RNA molecules are short-lived and fragile, constantly under threat from enzymes that degrade them. Unlike the more stable ...